{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:32:38Z","timestamp":1790087558084,"version":"4.0.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["107-2314-B-182A-140-MY3"],"award-info":[{"award-number":["107-2314-B-182A-140-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG3H1001"],"award-info":[{"award-number":["CMRPG3H1001"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00216","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T23:56:55Z","timestamp":1582588615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Chi-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann-Lii","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir-Hwa","family":"Ueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Ting","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.30162","article-title":"Clinical manifestations and outcomes of patients with sarcomatoid hepatocellular carcinoma","volume":"69","author":"Liao","year":"2019","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbcan.2017.10.002","article-title":"New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies","volume":"1868","author":"Niu","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrclinonc.2014.136","article-title":"Liver cancer: time to evolve trial design after everolimus failure","volume":"11","author":"Llovet","year":"2014","journal-title":"Nat Rev Clin Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrgastro.2014.10","article-title":"HCC therapies\u2013lessons learned","volume":"11","author":"Worns","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/15680096113139990075","article-title":"Targeting tyrosine kinase receptors in hepatocellular carcinoma","volume":"13","author":"Muntane","year":"2013","journal-title":"Curr Cancer Drug Targets."},{"key":"B6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4254\/wjh.v9.i18.797","article-title":"Systemic treatment of hepatocellular carcinoma: past, present and future","volume":"9","author":"Cidon","year":"2017","journal-title":"World J Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E412","DOI":"10.3390\/cancers10110412","article-title":"Systemic therapy for hepatocellular carcinoma: latest advances","volume":"10","author":"Kudo","year":"2018","journal-title":"Cancers."},{"key":"B8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3748\/wjg.v18.i6.498","article-title":"Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications","volume":"18","author":"Frenette","year":"2012","journal-title":"World J Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1574884710666151020100059","article-title":"Advances in the pharmacologic treatment of hepatocellular carcinoma","volume":"10","author":"Bhayani","year":"2015","journal-title":"Curr Clin Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1055\/s-0033-1333632","article-title":"Emerging targeted strategies in advanced hepatocellular carcinoma","volume":"33","author":"Finn","year":"2013","journal-title":"Semin Liver Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/1078-0432.CCR-13-0547","article-title":"Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design","volume":"20","author":"Llovet","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.3748\/wjg.v20.i15.4115","article-title":"Hepatocellular carcinoma review: current treatment, and evidence-based medicine","volume":"20","author":"Raza","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00280-013-2223-9","article-title":"Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?","volume":"72","author":"Petta","year":"2013","journal-title":"Cancer Chemother Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/CS20120504","article-title":"Histone deacetylases as targets for treatment of multiple diseases","volume":"124","author":"Tang","year":"2013","journal-title":"Clin Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2009.02.042","article-title":"Enhancing the apoptotic and therapeutic effects of HDAC inhibitors","volume":"280","author":"Frew","year":"2009","journal-title":"Cancer Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.3390\/nu6104273","article-title":"The role of dietary histone deacetylases (HDACs) inhibitors in health and disease","volume":"6","author":"Bassett","year":"2014","journal-title":"Nutrients."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1111\/febs.13746","article-title":"How do tumor cells respond to HDAC inhibition?","volume":"283","author":"Newbold","year":"2016","journal-title":"FEBS J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jcp.25427","article-title":"Targeting the breast cancer kinome","volume":"232","author":"Miller","year":"2017","journal-title":"J Cell Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/hepr.12757","article-title":"Histone deacetylases function as novel potential therapeutic targets for cancer","volume":"47","author":"Zhang","year":"2017","journal-title":"Hepatol Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-1-4614-0254-1_14","article-title":"Histone deacetylase inhibitor: antineoplastic agent and radiation modulator","volume":"720","author":"Konsoula","year":"2011","journal-title":"Adv Exp Med Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-12-394387-3.00004-5","article-title":"HDAC inhibitor modulation of proteotoxicity as a therapeutic approach in cancer","volume":"116","author":"McConkey","year":"2012","journal-title":"Adv Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/jcp.24362","article-title":"Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells","volume":"228","author":"Hamed","year":"2013","journal-title":"J Cell Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1158\/1078-0432.CCR-12-3909","article-title":"Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo","volume":"20","author":"Chen","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","article-title":"Targeting apoptosis pathways in cancer by Chinese medicine","volume":"332","author":"Li-Weber","year":"2013","journal-title":"Cancer Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"268963","DOI":"10.1155\/2013\/268963","article-title":"Traditional herbal medicine: a review of potential of inhibitory hepatocellular carcinoma in basic research and clinical trial","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid Based Complement Alternat Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"21703","DOI":"10.3390\/ijms151221703","article-title":"Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer","volume":"15","author":"Terlikowska","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E893","DOI":"10.3390\/ijms17060893","article-title":"Cancer stem cells: the potential targets of chinese medicines and their active compounds","volume":"17","author":"Hong","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.21873\/anticanres.12046","article-title":"Anticancer activity of artemisinin and its derivatives","volume":"37","author":"Slezakova","year":"2017","journal-title":"Anticancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3181\/00379727-207-2320227","article-title":"Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects","volume":"232","author":"Myzak","year":"2007","journal-title":"Exp Biol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.phrs.2016.05.028","article-title":"Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer","volume":"111","author":"Liu","year":"2016","journal-title":"Pharmacol Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.lfs.2018.10.034","article-title":"Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells","volume":"213","author":"Yang","year":"2018","journal-title":"Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"23342","DOI":"10.18632\/oncotarget.4344","article-title":"Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E380","DOI":"10.3390\/ijms19020380","article-title":"Corylin Suppresses hepatocellular carcinoma progression via the inhibition of epithelial-mesenchymal transition, mediated by long noncoding RNA GAS5","volume":"19","author":"Chen","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41419-018-0575-0","article-title":"Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e28103","DOI":"10.1371\/journal.pone.0028103","article-title":"Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1\/S cell cycle proteins","volume":"6","author":"Noh","year":"2011","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.3390\/ijms18122655","article-title":"Dihydrocoumarin, an HDAC inhibitor, increases DNA damage sensitivity by inhibiting Rad52","volume":"18","author":"Chen","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2407-9-395","article-title":"High class I HDAC activity and expression are associated with RelA\/p65 activation in pancreatic cancer in vitro and in vivo","volume":"9","author":"Lehmann","year":"2009","journal-title":"BMC Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbcan.2014.07.010","article-title":"Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis","volume":"1846","author":"Wagner","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1038\/onc.2015.444","article-title":"HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer","volume":"35","author":"Ruscetti","year":"2016","journal-title":"Oncogene."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e2063","DOI":"10.1038\/cddis.2015.328","article-title":"Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e14460","DOI":"10.1371\/journal.pone.0014460","article-title":"Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma","volume":"5","author":"Wu","year":"2010","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1007\/s10620-013-2867-7","article-title":"The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma","volume":"58","author":"Wu","year":"2013","journal-title":"Dig Dis Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.18632\/oncoscience.420","article-title":"The therapeutic properties of resminostat for hepatocellular carcinoma","volume":"5","author":"Zhao","year":"2018","journal-title":"Oncoscience."},{"key":"B45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00204-014-1430-4","article-title":"Biology of the cell cycle inhibitor p21(CDKN1A): molecular mechanisms and relevance in chemical toxicology","volume":"89","author":"Dutto","year":"2015","journal-title":"Arch Toxicol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1128\/MCB.01064-07","article-title":"Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications","volume":"27","author":"Batta","year":"2007","journal-title":"Mol Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers7010030","article-title":"p53 Acetylation: regulation and consequences","volume":"7","author":"Reed","year":"2014","journal-title":"Cancers."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1128\/MCB.26.7.2782-2790.2006","article-title":"Acetylation of p53 at lysine 373\/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1\/Cip1)","volume":"26","author":"Zhao","year":"2006","journal-title":"Mol Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1586\/era.10.62","article-title":"Nonhistone protein acetylation as cancer therapy targets","volume":"10","author":"Singh","year":"2010","journal-title":"Expert Rev Anticancer Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1566524011313040013","article-title":"Immunomodulatory effects of histone deacetylase inhibitors","volume":"13","author":"Licciardi","year":"2013","journal-title":"Curr Mol Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/annonc\/mdp270","article-title":"Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)","volume":"21","author":"Molife","year":"2010","journal-title":"Ann Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7150\/ijms.5011","article-title":"Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells","volume":"9","author":"Lee","year":"2012","journal-title":"Int J Med Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ijc.29698","article-title":"Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir","volume":"138","author":"Hui","year":"2016","journal-title":"Int J Cancer."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E496","DOI":"10.3390\/ijms19020496","article-title":"Histone deacetylase inhibitor induced radiation sensitization effects on human cancer cells after photon and hadron radiation exposure","volume":"19","author":"Gerelchuluun","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1002\/ijc.28924","article-title":"Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism","volume":"135","author":"Hui","year":"2014","journal-title":"Int J Cancer."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0127058","DOI":"10.1371\/journal.pone.0127058","article-title":"The HDAC inhibitors scriptaid and LBH589 combined with the oncolytic virus delta24-RGD exert enhanced anti-tumor efficacy in patient-derived glioblastoma cells","volume":"10","author":"Berghauser Pont","year":"2015","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12885-016-2957-y","article-title":"Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and\/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial","volume":"16","author":"Caponigro","year":"2016","journal-title":"BMC Cancer."},{"key":"B58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1158\/1535-7163.MCT-12-0811","article-title":"Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus","volume":"12","author":"Hui","year":"2013","journal-title":"Mol Cancer Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbrc.2013.05.088","article-title":"Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells","volume":"436","author":"Li","year":"2013","journal-title":"Biochem Biophys Res Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3390\/biom10010020","article-title":"Suppression of hepatocellular carcinoma progression through FOXM1 and EMT inhibition via hydroxygenkwanin-induced miR-320a expression","volume":"10","author":"Chou","year":"2019","journal-title":"Biomolecules."},{"key":"B61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/epi.3.1.5736","article-title":"HDACs and HDAC inhibitors in colon cancer","volume":"3","author":"Mariadason","year":"2008","journal-title":"Epigenetics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5301\/tj.5000347","article-title":"HDAC inhibitors: a new radiosensitizer for non-small-cell lung cancer","volume":"101","author":"Zhu","year":"2015","journal-title":"Tumori."},{"key":"B63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21873\/anticanres.11286","article-title":"Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer","volume":"37","author":"Damaskos","year":"2017","journal-title":"Anticancer Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","article-title":"Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer","volume":"835","author":"Heers","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00403-006-0725-6","article-title":"Strong expression of a longevity-related protein, SIRT1, in Bowen's disease","volume":"299","author":"Hida","year":"2007","journal-title":"Arch Dermatol Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/modpathol.2009.49","article-title":"SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer","volume":"22","author":"Nosho","year":"2009","journal-title":"Mod Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000334577","article-title":"Histone deacetylase in chronic lymphocytic leukemia","volume":"81","author":"Wang","year":"2011","journal-title":"Oncology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/pros.22592","article-title":"SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells","volume":"73","author":"Lovaas","year":"2013","journal-title":"Prostate."},{"key":"B69","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1021\/acs.jmedchem.7b00533","article-title":"Discovery and characterization of R\/S-N-3-cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1- benzopyran-4-yl)urea, a new histone deacetylase class III inhibitor exerting antiproliferative activity against cancer cell lines","volume":"60","author":"Schnekenburger","year":"2017","journal-title":"J Med Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1158\/0008-5472.CAN-06-4152","article-title":"Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays","volume":"67","author":"Stark","year":"2007","journal-title":"Cancer Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1158\/2159-8290.CD-11-0181","article-title":"Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas","volume":"1","author":"Taylor","year":"2011","journal-title":"Cancer Discov."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T23:56:57Z","timestamp":1582588617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":71,"alternative-id":["10.3389\/fonc.2020.00216"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00216","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"article-number":"216"}}